Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2023-10-11 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice from Neuland Laboratories Limited to stock exchanges about an upcoming Board Meeting scheduled for November 7, 2023. The purpose of the meeting is to approve and take on record the unaudited financial results for the quarter and half year ended September 30, 2023. The document also mentions the closure of the trading window in accordance with the Insider Trading Code. The document is short (1458 characters) and serves as an announcement of a future event (Board Meeting) rather than containing any financial results or detailed reports. It does not contain actual financial data or detailed management discussion. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement informing the stock exchanges and public about the Board Meeting and related compliance matters.
2023-10-11 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2023. It is a compliance certificate from the Registrar and Share Transfer Agent, submitted to stock exchanges. The document is short (1010 characters) and does not contain financial statements or substantive financial data. It is primarily a regulatory compliance certificate, not a financial report or announcement of voting results, management changes, or capital changes. Therefore, it fits best under Regulatory Filings (RNS).
2023-10-09 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates by shareholders and the issuance of a 'Letter of Confirmation' in lieu of physical share certificates. It references Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is about notifying the exchange of a shareholder-related event, specifically the loss of share certificates, and does not contain financial data, management discussion, voting results, or other report types. This fits the category of a Regulatory Filing (RNS) as it is a compliance-related announcement that does not fit other specific categories like Director's Dealing or Share Issue/Capital Change. The document length is short (1308 characters), and it is an official notification to the exchange rather than a report or announcement of a report publication.
2023-10-02 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the closure of the trading window pursuant to the company's Insider Trading Code. It mentions the upcoming declaration of financial results for the quarter and half year ended September 30, 2023, but does not contain any financial data or results itself. The document is an announcement related to trading restrictions ahead of financial results, not the results or report itself. The length is only 1203 characters, indicating it is a brief notice. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-09-26 English
Resignation of Independent director
Regulatory Filings
2023-09-25 English
Resignation
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the resignation of an Independent Director of the company. It references compliance with SEBI Listing Regulations and provides details about the director's resignation, including the reason and effective date. There are no financial statements, earnings data, or report attachments. The content is focused on management/board changes, specifically the resignation of a board member. Therefore, this fits the category of Board/Management Information (MANG). The document length is 4273 characters, which is consistent with a detailed announcement but not a full report.
2023-09-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.